ProFound AI Risk Outperforms Traditional, Widely-Accepted Breast Cancer Risk Models for Both Short-term and Long-term Risk Assessments
April 04, 2023 08:00 ET
|
iCAD, Inc.
NASHUA, N.H., April 04, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced new...
iCAD Reports Financial Results for Fourth Quarter ended December 31, 2022 and Year End
March 28, 2023 16:01 ET
|
iCAD, Inc.
Strategy focused on profitability by end of 2024, using current cash on hand New leadership to host conference call and webcast today at 4:30 PM ET NASHUA, N.H., March 28, 2023 (GLOBE NEWSWIRE)...
iCAD’s Breast AI Suite Empowers Customers to Lead the Way in Support of FDA’s National Breast Density Reporting Standard
March 23, 2023 08:00 ET
|
iCAD, Inc.
NASHUA, N.H., March 23, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced its...
iCAD Previews Fourth Quarter Financial Results, Full Report on March 28, 2023
March 13, 2023 08:30 ET
|
iCAD, Inc.
NASHUA, N.H., March 13, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it...
iCAD Announces Leadership Transition
March 13, 2023 08:00 ET
|
iCAD, Inc.
Stacey Stevens Resigns as President and CEO and as a Member of the Board Dana Brown Named President and CEO, remains Chairman of the Board NASHUA, N.H., March 13, 2023 (GLOBE NEWSWIRE) -- iCAD,...
New Real-World Clinical Evidence Confirms ProFound AI Boosts Radiologists’ Efficiency and Accuracy
March 01, 2023 08:00 ET
|
iCAD, Inc.
NASHUA, N.H., March 01, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced new...
iCAD to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference
February 09, 2023 08:00 ET
|
iCAD, Inc.
NASHUA, N.H., Feb. 09, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced the Company...
iCAD Announces CFO Transition and Hires New Senior Vice President, US Commercial Sales, AI
January 23, 2023 08:00 ET
|
iCAD, Inc.
Daniel Shea appointed as interim Chief Financial Officer William Keyes hired as Senior Vice President, US Commercial Sales, AI NASHUA, N.H., Jan. 23, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ:...
iCAD Announces Board of Directors Transition
January 11, 2023 08:00 ET
|
iCAD, Inc.
NASHUA, N.H., Jan. 11, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced the...
iCAD features Solis Mammography in upcoming “ProFound Insights, ProFound Impact” webinar
December 08, 2022 08:00 ET
|
iCAD, Inc.
NASHUA, N.H., Dec. 08, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced Solis...